ended4월 4일· 1 sources
Tariff Ultimatum Forces Pharma Industry into Manufacturing and Pricing Negotiations
트럼프의 의약품 100% 관세, 제약사들을 협상 테이블로 강제
Why it matters
Trump's 100% tariff on patented medicines is a leverage-based strategy to reshape US pharmaceutical manufacturing and drug pricing. Major drug makers are negotiating exemptions through manufacturing commitments or government pricing deals, but smaller competitors face real financial pressure. This marks a significant shift in using tariffs as a tool to influence healthcare economics and domestic supply chain resilience.
1
Sources
+0
24h
—
Growth
170d
Active
Pharma tariffsManufacturing incentivesDrug pricingMedicaid dealsTrade leverage